To clarify methodological and programmatic aspects of the study “Deterioration of Immunization Resilience: A Bayesian Machine Learning Assessment of the 2025-2026 Measles Outbreak in Mexico.”
Approach:
Confidence vs credibility interval: The authors acknowledge that the reported Bayesian interval is a posterior credibility interval. Its width, 64.45% to 100.00%, reflects substantial uncertainty regarding immunization coverage recovery.
Negative R²: The authors acknowledge that the out-of-sample R² of −0.36 indicates poor predictive fit for the 2025 data point and performance worse than a horizontal mean line.
Predictive modeling vs programmatic perspective: The response explains that models based on historical data assume continuity and cannot readily account for abrupt interventions. The model was intended to establish a baseline risk scenario without extraordinary public health measures.
Key Findings:
Complete immunization recovery remains mathematically possible because the interval includes the World Health Organization’s 95% threshold, but exceptional public health measures would be required.
The 2025 outbreak represented a drastic departure from the preceding 10-year trend.
Emergency catch-up campaigns, international collaborations, and geographically targeted interventions could alter the modeled trajectory.
Interpretation:
Predictive machine learning assessments should be integrated with programmatic realities when developing policies to address immunization gaps in Mexico.
Limitations:
The model’s poor fit for the 2025 data point limits its reliability for forecasting 2026.
Retrospective smoothing cannot adequately capture the 2025 outlier, contributing to the exceptionally wide credibility interval.
Conclusion:
The response clarifies that the model estimates baseline risk rather than the effects of extraordinary interventions intended to disrupt outbreak progression.
Recent CDC advisories, testing updates, and immunization recommendations highlight developments in infectious diseases, immunization, and diagnostic testing relevant to physicians across multiple specialties.